Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Perry

Showing results (471-480 of 628) with videos related to

Pageof 63
Sort By:
Current Medicinal Chemistry|May 17, 2005
Therapeutic opportunities in Alzheimer disease: one for all or all for one?Michael W Marlatt, Kate M Webber, Paula I Moreira, et al.
IUBMB Life|November 7, 2012
The impairment of insulin signaling in Alzheimer's diseaseEmanuel Candeias, Ana I Duarte, Cristina Carvalho, et al.
Journal of Neuropathology and Experimental Neurology|February 10, 2012
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neuronsAkihiko Nunomura, Toshio Tamaoki, Nobutaka Motohashi, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic TargetsSusana Cardoso, Renato Santos, Sonia Correia, et al.
Journal of Bioenergetics and Biomembranes|October 16, 2009
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxiaCristina Carvalho, Sónia C Correia, Renato X Santos, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2024
Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's diseaseYanbin Xiyang, Ju Gao, Mao Ding, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's diseaseRoberta Borghi, Alessandra Piccini, Erica Barini, et al.
Mechanisms of Ageing and Development|June 7, 2005
The cell cycle in Alzheimer disease: a unique target for neuropharmacologyKate M Webber, Arun K Raina, Michael W Marlatt, et al.
Human Molecular Genetics|October 4, 2017
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent modelWenzhang Wang, Jun Yin, Xiaopin Ma, et al.
Free Radical Biology & Medicine|July 11, 2002
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesisMiguel A Pappolla, Mark A Smith, Tara Bryant-Thomas, et al.
Pageof 63

Showing results (471-480 of 628) with videos related to

Sort By:
Pageof 63
Current Medicinal Chemistry|May 17, 2005
Therapeutic opportunities in Alzheimer disease: one for all or all for one?Michael W Marlatt, Kate M Webber, Paula I Moreira, et al.
IUBMB Life|November 7, 2012
The impairment of insulin signaling in Alzheimer's diseaseEmanuel Candeias, Ana I Duarte, Cristina Carvalho, et al.
Journal of Neuropathology and Experimental Neurology|February 10, 2012
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neuronsAkihiko Nunomura, Toshio Tamaoki, Nobutaka Motohashi, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic TargetsSusana Cardoso, Renato Santos, Sonia Correia, et al.
Journal of Bioenergetics and Biomembranes|October 16, 2009
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxiaCristina Carvalho, Sónia C Correia, Renato X Santos, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2024
Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's diseaseYanbin Xiyang, Ju Gao, Mao Ding, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's diseaseRoberta Borghi, Alessandra Piccini, Erica Barini, et al.
Mechanisms of Ageing and Development|June 7, 2005
The cell cycle in Alzheimer disease: a unique target for neuropharmacologyKate M Webber, Arun K Raina, Michael W Marlatt, et al.
Human Molecular Genetics|October 4, 2017
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent modelWenzhang Wang, Jun Yin, Xiaopin Ma, et al.
Free Radical Biology & Medicine|July 11, 2002
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesisMiguel A Pappolla, Mark A Smith, Tara Bryant-Thomas, et al.
Pageof 63